Navigation Links
FDA Accepts New Drug Application for Bucindolol, A Genetically-Targeted Treatment for Heart Failure From ARCA biopharma
Date:9/23/2008

annot efficiently pump blood to meet the body's oxygen demands. The American Heart Association estimates that about six million Americans are living with heart failure, with 550,000 new cases diagnosed annually. Heart failure accounts directly for 55,000 deaths and indirectly for an additional 230,000 deaths in the United States each year. Heart failure is the underlying reason for approximately 12 to 15 million annual visits to physicians and 6.5 million annual hospital days.

About ARCA biopharma

ARCA biopharma, Inc. is a privately held company focused on developing and commercializing genetically targeted therapies for heart failure and other cardiovascular diseases. The Company's lead product, Gencaro(TM) (bucindolol hydrochloride)*, is an investigational, pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. ARCA biopharma, in partnership with Laboratory Corporation of America (NYSE: LH), is developing a companion genetic test for bucindolol. For more information please visit http://www.arcabiopharma.com.

* The tradename Gencaro(TM) is currently pending regulatory including FDA approval.


'/>"/>
SOURCE ARCA biopharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
2. FDA Accepts Sucampos sNDA for Lubiprostone (8 mcg) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)
3. FDA Accepts Ranexa(R) sNDA and NDA for Filing
4. EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes
5. Imaging Diagnostic Systems Accepts Resignations of Outside Directors
6. U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile
7. FDA Accepts Zingo(TM) Supplemental New Drug Application to Reduce Pain Associated With Peripheral Needle Insertion Procedures in Adults
8. FDA Accepts Immucors Response to Warning Letter
9. Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period
10. GSI Group Accepts Shares in Tender Offer for Excel Technology and Commences Subsequent Offering Period
11. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2012)... to voice concern on biosimilars pathways for patients with ... offered oral testimony at last week,s U.S. ... guidance of biosimilars products. IDF urged the FDA to ... order to protect the safety of patients with PIDD. ... an immune system that is either absent or hindered ...
(Date:5/16/2012)... May 16, 2012  UV Flu Technologies, ... to announce that it has signed a television ... San Bernardino Ca., for the filming of a ... "mini-infomercial." The commercial will run locally, regionally, and ... Comcast and Direct TV. The commercials will be ...
(Date:5/16/2012)... MAHWAH, N.J., May 16, 2012 /PRNewswire-Asia-FirstCall/ -- Mindray ... a leading developer, manufacturer and marketer of medical ... L.P., (HealthTrust) is renewing its agreement for its ... With this agreement, Mindray provides monitoring that ... hospital departments and outpatient surgery centers for HealthTrust ...
(Date:5/15/2012)... Vermillion, Inc. (NASDAQ: VRML ), ... results for the first quarter ended March 31, 2012. ... In Q1, the volume of OVA1®, the company,s flagship ... ovarian masses, was generally in line with the forecast ... increase of 28% to 3,952 from the same year-ago ...
Breaking Biology Technology:Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway 2UV Flu Technologies to Commence a National TV Advertising Campaign 2UV Flu Technologies to Commence a National TV Advertising Campaign 3Mindray Renews Agreement with HealthTrust Purchasing Group, L.P. to Provide Patient Monitoring Equipment 2Vermillion Reports First Quarter 2012 Results 2Vermillion Reports First Quarter 2012 Results 3Vermillion Reports First Quarter 2012 Results 4Vermillion Reports First Quarter 2012 Results 5Vermillion Reports First Quarter 2012 Results 6Vermillion Reports First Quarter 2012 Results 7Vermillion Reports First Quarter 2012 Results 8
... COLUMBUS, Ohio -- Engineers at Ohio State University are ... from the same material found in pencils. , Experts ... found in graphite pencils -- holds the key to ... effects that could enable new kinds of electronics. , ...
... VIEW, Calif., March 31 Based on its recent analysis ... Polymers LLC with the 2009 North American Frost & Sullivan ... to lead innovation in the field of styrenic block copolymers ... over four decades, the company,s new family of SBCs, the ...
... Pharmaceuticals, Inc. (NYSE: WPI ), a leading ... District Court for the District of Delaware has ruled ... tablets) does not infringe United States Patent No. 6,919,373 ... invalid. The opinion, dated March 30, 2009, was ...
Other Biology Technology:Researchers find better way to manufacture fast computer chips 2Researchers find better way to manufacture fast computer chips 3Frost & Sullivan Recognizes Kraton Polymers for Developing a New Generation of Polymer Grades Suitable for High-Speed Processing in Nonwoven Manufacture 2Frost & Sullivan Recognizes Kraton Polymers for Developing a New Generation of Polymer Grades Suitable for High-Speed Processing in Nonwoven Manufacture 3Frost & Sullivan Recognizes Kraton Polymers for Developing a New Generation of Polymer Grades Suitable for High-Speed Processing in Nonwoven Manufacture 4Frost & Sullivan Recognizes Kraton Polymers for Developing a New Generation of Polymer Grades Suitable for High-Speed Processing in Nonwoven Manufacture 5Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid 2
(Date:5/21/2012)... 2012  Chiltern International Limited (Chiltern), a global ... been recognized with a CRO Leadership Award in ... Regulatory. The awards are given by Life Science ... Nice Insight. Glenn Kerkhof ... be recognized as a CRO leader in the ...
(Date:5/21/2012)... (WHOI) have conducted a new study to measure levels ... The study, recently published in the journal Biogeosciences ... the Arctic Ocean,s carbon cyclethe pathway through which carbon ... will also offer an important point of reference for ... and how the ecosystem responds to rising global temperatures. ...
(Date:5/21/2012)... FLA.Robert van Woesik, Florida Institute of Technology professor ... grant from the National Science Foundation for research ... project will develop quantitative approaches to assess the ... are decimating the corals. When diseases cluster they ... a secondary cause of infection., Although diseases are ...
Breaking Biology News(10 mins):Chiltern Wins CRO Leadership Award From Life Science Leader 2New study by WHOI scientists provides baseline measurements of carbon in Arctic Ocean 2New study by WHOI scientists provides baseline measurements of carbon in Arctic Ocean 3Acne Psoriasis Meds Dont Raise Fracture Risk 72216 1Survey Finds Those Over 50 Are Less Stressed 72213 1Survey Finds Those Over 50 Are Less Stressed 72213 2Survey Finds Those Over 50 Are Less Stressed 72213 3Euthanasia and the use of end of life drugs without explicit request 72210 1Euthanasia and the use of end of life drugs without explicit request 72210 2
... and Switzerland has shown that carbon nanotubes may be ... 21 in the advance online edition of the journal ... in the search to find ways to "bypass" faulty ... which, like neurons, are highly electrically conductive, form extremely ...
... BOSTON, Mass. (Dec. 21, 2008) Modern humans left Africa ... was responsible for nearly all of the human population that ... that men and women weren,t equal partners in that exodus. ... non-sex chromosomes, the researchers found evidence that men probably outnumbered ...
... Washington, DC U.S. Forest Service Southern Research Station ... Presidential Early Career Award for Scientists and Engineers during ... among the nearly 70 scientists and engineers receiving the ... scientist or engineer can receive in the United States. ...
Other Biology News:New 'smart' materials for the brain 2Haag honored with Presidential Early Career Scientists Award 2
Anti-Chicken IgY, (IgG) F(ab')2 Fragment Specific....
Presenilin 2 Immunogen: Synthetic peptide corresponding to residues 31-47 of human Presenilin 2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Recognizes TWIK-2. Does not cross react with any other known proteins....
Sheep polyclonal to ErbB 2 ( Abpromise for all tested applications). Antigen: Recombinant full length c-ErbB2 protein (Human). Entrez GeneID: 2064 Swiss Protein ID: P04626...
Biology Products: